Medidata and CTI Clinical Trial and Consulting have expanded their 12-year relationship. The new agreement places the Medidata Patient Experience and its essential, industry-leading solution, Medidata eCOA, at the heart of CTI’s patient-centric research and innovation, elevating data integrity and expediting the delivery of life-changing medicines. Through this deepened collaboration, CTI is accredited in Medidata eCOA to further improve data collection capabilities, enhancing the clinical trial experience for patients by enabling the collection of real-time, high-quality data through easy-to-use digital applications. As a result, there will be seamless integration for both patients and study teams as Medidata eCOA will be working alongside Medidata Rave EDC – a solution already used by CTI – and other Medidata solutions on the Medidata Platform.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DASTY:
- Dassault Systemes price target lowered to EUR 30.30 from EUR 34 at Berenberg
- Dassault Systemes price target lowered to EUR 23 from EUR 24 at Jefferies
- Dassault Systemes price target lowered to EUR 30 from EUR 33 at JPMorgan
- Dassault Systèmes Reports Strong Q3 2025 Performance
- Dassault Systèmes Earnings Call: Subscription Growth Shines